Rankings
▼
Calendar
▼
Sectors
/
Biotechnology
(500 companies)
#
Ticker
Company
Mkt Cap
1
VRTX
Vertex Pharmaceuticals Incorporated
$110B
2
REGN
Regeneron Pharmaceuticals, Inc.
$78B
3
ARGX
argenx SE
$48B
4
ALNY
Alnylam Pharmaceuticals, Inc.
$41B
5
INSM
Insmed Incorporated
$29B
6
RVMD
Revolution Medicines, Inc.
$28B
7
BNTX
BioNTech SE
$26B
8
UTHR
United Therapeutics Corporation
$25B
9
RPRX
Royalty Pharma plc
$21B
10
MRNA
Moderna, Inc.
$20B
11
ROIV
Roivant Sciences Ltd.
$20B
12
INCY
Incyte Corporation
$19B
13
SMMT
Summit Therapeutics Inc.
$17B
14
GMAB
Genmab A/S
$17B
15
BBIO
BridgeBio Pharma, Inc.
$14B
16
ASND
Ascendis Pharma A/S
$14B
17
IONS
Ionis Pharmaceuticals, Inc.
$12B
18
JAZZ
Jazz Pharmaceuticals plc
$12B
19
MDGL
Madrigal Pharmaceuticals, Inc.
$12B
20
EXEL
Exelixis, Inc.
$12B
21
RNAM
Avidity Biosciences Inc
$11B
22
ARWR
Arrowhead Pharmaceuticals, Inc.
$10B
23
BMRN
BioMarin Pharmaceutical Inc.
$10B
24
AXSM
Axsome Therapeutics, Inc.
$10B
25
TECH
Bio-Techne Corporation
$8B
26
PCVX
Vaxcyte, Inc.
$8B
27
KRYS
Krystal Biotech, Inc.
$8B
28
CYTK
Cytokinetics, Incorporated
$8B
29
NUVL
Nuvalent, Inc.
$8B
30
HALO
Halozyme Therapeutics, Inc.
$8B
31
IBRX
ImmunityBio, Inc.
$8B
32
ABVX
Abivax S.A.
$7B
33
PRAX
Praxis Precision Medicines, Inc.
$7B
34
KYMR
Kymera Therapeutics, Inc.
$7B
35
ACLX
Arcellx, Inc.
$7B
36
ERAS
Erasca, Inc.
$7B
37
BLTE
Belite Bio, Inc
$6B
38
PTGX
Protagonist Therapeutics, Inc.
$6B
39
COGT
Cogent Biosciences, Inc.
$6B
40
CNTA
Centessa Pharmaceuticals plc
$6B
41
TGTX
TG Therapeutics, Inc.
$6B
42
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
43
IMVT
Immunovant, Inc.
$6B
44
CGON
CG Oncology, Inc. Common stock
$6B
45
CELC
Celcuity Inc.
$6B
46
CAI
Caris Life Sciences, Inc.
$6B
47
PTCT
PTC Therapeutics, Inc.
$6B
48
ALKS
Alkermes plc
$6B
49
SRRK
Scholar Rock Holding Corporation
$5B
50
APLS
Apellis Pharmaceuticals, Inc.
$5B
51
CORT
Corcept Therapeutics Incorporated
$5B
52
CRSP
CRISPR Therapeutics AG
$5B
53
APGE
Apogee Therapeutics, Inc.
$5B
54
TERN
Terns Pharmaceuticals, Inc.
$5B
55
MIRM
Mirum Pharmaceuticals, Inc.
$5B
56
LGND
Ligand Pharmaceuticals Incorporated
$5B
57
FOLD
Amicus Therapeutics, Inc.
$5B
58
LEGN
Legend Biotech Corporation
$4B
59
XENE
Xenon Pharmaceuticals Inc.
$4B
60
SYRE
Spyre Therapeutics, Inc.
$4B
61
CRNX
Crinetics Pharmaceuticals, Inc.
$4B
62
VKTX
Viking Therapeutics, Inc.
$4B
63
ACAD
ACADIA Pharmaceuticals Inc.
$4B
64
TVTX
Travere Therapeutics, Inc.
$4B
65
TLX
Telix Pharmaceuticals Limited
$4B
66
NAMS
NewAmsterdam Pharma Company N.V.
$3B
67
EWTX
Edgewise Therapeutics, Inc.
$3B
68
DNTH
Dianthus Therapeutics, Inc.
$3B
69
CPRX
Catalyst Pharmaceuticals, Inc.
$3B
70
LQDA
Liquidia Corporation
$3B
71
KNSA
Kiniksa Pharmaceuticals, Ltd.
$3B
72
DNLI
Denali Therapeutics Inc.
$3B
73
ALMS
Alumis Inc. Common Stock
$3B
74
DYN
Dyne Therapeutics, Inc.
$3B
75
TNGX
Tango Therapeutics, Inc.
$3B
76
ARQT
Arcutis Biotherapeutics, Inc.
$3B
77
BEAM
Beam Therapeutics Inc.
$3B
78
SLNO
Soleno Therapeutics, Inc.
$3B
79
VCYT
Veracyte, Inc.
$3B
80
ADMA
ADMA Biologics, Inc.
$3B
81
RLAY
Relay Therapeutics, Inc.
$3B
82
IDYA
IDEAYA Biosciences, Inc.
$3B
83
ELVN
Enliven Therapeutics, Inc.
$3B
84
IRON
Disc Medicine, Inc.
$3B
85
TARS
Tarsus Pharmaceuticals, Inc.
$3B
86
GPCR
Structure Therapeutics Inc.
$3B
87
VERA
Vera Therapeutics, Inc.
$3B
88
RCUS
Arcus Biosciences, Inc.
$3B
89
ORKA
Oruka Therapeutics, Inc.
$3B
90
ZLAB
Zai Lab Limited
$3B
91
MANE
Veradermics, Incorporated
$2B
92
KOD
Kodiak Sciences Inc.
$2B
93
RARE
Ultragenyx Pharmaceutical Inc.
$2B
94
ANAB
AnaptysBio, Inc.
$2B
95
DFTX
Definium Therapeutics, Inc.
$2B
96
AAPG
Ascentage Pharma Group International
$2B
97
DAWN
Day One Biopharmaceuticals, Inc.
$2B
98
CLDX
Celldex Therapeutics, Inc.
$2B
99
ADPT
Adaptive Biotechnologies Corporation
$2B
100
SRPT
Sarepta Therapeutics, Inc.
$2B
101
AUPH
Aurinia Pharmaceuticals Inc.
$2B
102
ZYME
Zymeworks Inc.
$2B
103
IMNM
Immunome, Inc.
$2B
104
OCUL
Ocular Therapeutix, Inc.
$2B
105
MESO
Mesoblast Limited
$2B
106
STOK
Stoke Therapeutics, Inc.
$2B
107
TYRA
Tyra Biosciences, Inc.
$2B
108
GLPG
Galapagos N.V.
$2B
109
SNDX
Syndax Pharmaceuticals, Inc.
$2B
110
PHVS
Pharvaris N.V.
$2B
111
INBX
Inhibrx Biosciences, Inc.
$2B
112
BCRX
BioCryst Pharmaceuticals, Inc.
$2B
113
NKTR
Nektar Therapeutics
$2B
114
TRVI
Trevi Therapeutics, Inc.
$2B
115
MLYS
Mineralys Therapeutics, Inc.
$2B
116
HRMY
Harmony Biosciences Holdings, Inc.
$2B
117
VCEL
Vericel Corporation
$2B
118
NUVB
Nuvation Bio Inc.
$2B
119
SION
Sionna Therapeutics, Inc.
$2B
120
NTLA
Intellia Therapeutics, Inc.
$2B
121
NBTX
Nanobiotix S.A.
$2B
122
VIR
Vir Biotechnology, Inc.
$2B
123
TSHA
Taysha Gene Therapies, Inc.
$2B
124
CAPR
Capricor Therapeutics, Inc.
$2B
125
RXRX
Recursion Pharmaceuticals, Inc.
$2B
126
MNMD
Mind Medicine (MindMed) Inc.
$2B
127
OCS
Oculis Holding AG
$2B
128
IMTX
Immatics N.V.
$2B
129
INVA
Innoviva, Inc.
$2B
130
AGIO
Agios Pharmaceuticals, Inc.
$1B
131
IMCR
Immunocore Holdings plc
$1B
132
PVLA
Palvella Therapeutics, Inc.
$1B
133
NRIX
Nurix Therapeutics, Inc.
$1B
134
ARDX
Ardelyx, Inc.
$1B
135
AMLX
Amylyx Pharmaceuticals, Inc.
$1B
136
AVBP
ArriVent BioPharma, Inc. Common Stock
$1B
137
OLMA
Olema Pharmaceuticals, Inc.
$1B
138
WVE
Wave Life Sciences Ltd.
$1B
139
CRVS
Corvus Pharmaceuticals, Inc.
$1B
140
RAPP
Rapport Therapeutics, Inc. Common Stock
$1B
141
NVAX
Novavax, Inc.
$1B
142
GLUE
Monte Rosa Therapeutics, Inc.
$1B
143
MAZE
Maze Therapeutics, Inc.
$1B
144
ABCL
AbCellera Biologics Inc.
$1B
145
ANABV
AnaptysBio, Inc. Common Stock When Issued
$1B
146
PGEN
Precigen, Inc.
$1B
147
BCAX
Bicara Therapeutics Inc. Common Stock
$1B
148
MLTX
MoonLake Immunotherapeutics
$1B
149
GHRS
GH Research PLC
$1B
150
PHAR
Pharming Group N.V.
$1B
151
URGN
UroGen Pharma Ltd.
$1B
152
VRDN
Viridian Therapeutics, Inc.
$1B
153
AKTS
Aktis Oncology, Inc.
$1B
154
EYPT
EyePoint Pharmaceuticals, Inc.
$1B
155
IOVA
Iovance Biotherapeutics, Inc.
$1B
156
SEPN
Septerna, Inc.
$1B
157
QURE
uniQure N.V.
$1B
158
MBX
MBX Biosciences, Inc. Common Stock
$1B
159
BHVN
Biohaven Ltd.
$1B
160
SVRA
Savara Inc.
$1B
161
XERS
Xeris Biopharma Holdings, Inc.
$1B
162
ORIC
ORIC Pharmaceuticals, Inc.
$1B
163
VTYX
Ventyx Biosciences, Inc.
$1B
164
KALV
KalVista Pharmaceuticals, Inc.
$1B
165
MRVI
Maravai LifeSciences Holdings, Inc.
$984M
166
GERN
Geron Corporation
$961M
167
XNCR
Xencor, Inc.
$960M
168
RAPT
RAPT Therapeutics, Inc.
$959M
169
OMER
Omeros Corporation
$959M
170
PHAT
Phathom Pharmaceuticals, Inc.
$925M
171
JANX
Janux Therapeutics, Inc.
$914M
172
FTRE
Fortrea Holdings Inc.
$905M
173
SANA
Sana Biotechnology, Inc.
$886M
174
LBRX
LB Pharmaceuticals Inc Common Stock
$879M
175
TBPH
Theravance Biopharma, Inc.
$843M
176
MNKD
MannKind Corporation
$830M
177
SPRY
ARS Pharmaceuticals, Inc.
$818M
178
KURA
Kura Oncology, Inc.
$817M
179
ZBIO
Zenas BioPharma, Inc.
$814M
180
ABUS
Arbutus Biopharma Corporation
$812M
181
JBIO
Jade Biosciences, Inc.
$806M
182
SGP
SpyGlass Pharma, Inc. Common Stock
$789M
183
ANRO
Alto Neuroscience, Inc.
$788M
184
TRAXV
First Tracks Biotherapeutics, Inc. Ordinary Shares When-Issued
$782M
185
ANL
Adlai Nortye Ltd.
$780M
186
DSGN
Design Therapeutics, Inc.
$776M
187
MGTX
MeiraGTx Holdings plc
$759M
188
CTMX
CytomX Therapeutics, Inc.
$752M
189
CMPX
Compass Therapeutics, Inc.
$719M
190
DRTS
Alpha Tau Medical Ltd.
$718M
191
ANNX
Annexon, Inc.
$710M
192
LXRX
Lexicon Pharmaceuticals, Inc.
$708M
193
BBOT
BridgeBio Oncology Therapeutics Inc.
$707M
194
DRUG
Bright Minds Biosciences Inc.
$684M
195
GYRE
Gyre Therapeutics, Inc.
$682M
196
TRAX
First Tracks Biotherapeutics Inc
$682M
197
CBIO
Crescent Biopharma, Inc.
$678M
198
PRME
Prime Medicine, Inc.
$670M
199
ARVN
Arvinas, Inc.
$665M
200
SLS
SELLAS Life Sciences Group, Inc.
$636M
201
ETON
Eton Pharmaceuticals, Inc.
$626M
202
SLDB
Solid Biosciences Inc.
$620M
203
CLYM
Climb Bio, Inc.
$615M
204
BIOA
BioAge Labs, Inc.
$614M
205
ZVRA
Zevra Therapeutics, Inc.
$596M
206
ABSI
Absci Corporation
$592M
207
CRMD
CorMedix Inc.
$584M
208
PRTA
Prothena Corporation plc
$577M
209
PROK
ProKidney Corp.
$567M
210
ALLO
Allogene Therapeutics, Inc.
$564M
211
RIGL
Rigel Pharmaceuticals, Inc.
$558M
212
AGMB
AgomAb Therapeutics N.V. American Depositary Shares
$543M
213
OCGN
Ocugen, Inc.
$537M
214
LYEL
Lyell Immunopharma, Inc.
$536M
215
TECX
Tectonic Therapeutic, Inc.
$536M
216
IMMX
Immix Biopharma, Inc.
$530M
217
RLMD
Relmada Therapeutics, Inc.
$525M
218
MDXG
MiMedx Group, Inc.
$515M
219
ADCT
ADC Therapeutics S.A.
$503M
220
DNA
Ginkgo Bioworks Holdings, Inc.
$489M
221
FDMT
4D Molecular Therapeutics, Inc.
$481M
222
AURA
Aura Biosciences, Inc.
$480M
223
TRDA
Entrada Therapeutics, Inc.
$479M
224
DBVT
DBV Technologies S.A.
$471M
225
VALN
Valneva SE
$471M
226
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
$463M
227
XOMA
XOMA Royalty Corp.
$453M
228
RGNX
REGENXBIO Inc.
$453M
229
GNFT
Genfit S.A.
$446M
230
ASMB
Assembly Biosciences, Inc.
$442M
231
LXEO
Lexeo Therapeutics, Inc. Common Stock
$438M
232
AVIR
Atea Pharmaceuticals, Inc.
$435M
233
KROS
Keros Therapeutics, Inc.
$429M
234
FULC
Fulcrum Therapeutics, Inc.
$425M
235
NGNE
Neurogene Inc.
$421M
236
VSTM
Verastem, Inc.
$414M
237
PRTC
PureTech Health plc
$413M
238
ENGN
enGene Holdings Inc.
$410M
239
KYTX
Kyverna Therapeutics, Inc.
$409M
240
VNDA
Vanda Pharmaceuticals Inc.
$406M
241
NMRA
Neumora Therapeutics, Inc. Common Stock
$405M
242
NAGE
Niagen Bioscience Inc
$397M
243
OVID
Ovid Therapeutics Inc.
$395M
244
CLLS
Cellectis S.A.
$393M
245
RCKT
Rocket Pharmaceuticals, Inc.
$388M
246
LRMR
Larimar Therapeutics, Inc.
$386M
247
FBRX
Forte Biosciences, Inc.
$384M
248
AUTL
Autolus Therapeutics plc
$383M
249
AKBA
Akebia Therapeutics, Inc.
$382M
250
PBYI
Puma Biotechnology, Inc.
$382M
251
YDES
YD Bio Limited Ordinary Shares
$376M
252
IRD
Opus Genetics, Inc.
$372M
253
STTK
Shattuck Labs, Inc.
$368M
254
SLN
Silence Therapeutics plc
$364M
255
CADL
Candel Therapeutics, Inc.
$358M
256
MNPR
Monopar Therapeutics Inc.
$351M
257
PALI
Palisade Bio, Inc.
$348M
258
ZURA
Zura Bio Limited
$346M
259
DMAC
DiaMedica Therapeutics Inc.
$339M
260
GLSI
Greenwich LifeSciences, Inc.
$337M
261
BCYC
Bicycle Therapeutics plc
$335M
262
NAUT
Nautilus Biotechnology, Inc.
$333M
263
EVMN
Evommune, Inc.
$327M
264
BNTC
Benitec Biopharma Inc.
$327M
265
XOMAP
XOMA Corporation
$316M
266
NGEN
NervGen Pharma Corp. Common stock
$315M
267
FHTX
Foghorn Therapeutics Inc.
$313M
268
AVXL
Anavex Life Sciences Corp.
$311M
269
ENTA
Enanta Pharmaceuticals, Inc.
$309M
270
ABEO
Abeona Therapeutics Inc.
$308M
271
AMRN
Amarin Corporation plc
$296M
272
RZLT
Rezolute, Inc.
$296M
273
LENZ
LENZ Therapeutics, Inc.
$295M
274
CGEN
Compugen Ltd.
$295M
275
ACIU
AC Immune S.A.
$292M
276
ZNTL
Zentalis Pharmaceuticals, Inc.
$286M
277
CABA
Cabaletta Bio, Inc.
$286M
278
EDIT
Editas Medicine, Inc.
$285M
279
NBP
NovaBridge Biosciences
$284M
280
STRO
Sutro Biopharma, Inc.
$279M
281
HELP
Cybin Inc. Common Stock
$277M
282
ALEC
Alector, Inc.
$271M
283
IVA
Inventiva S.A.
$267M
284
ARTV
Artiva Biotherapeutics, Inc.
$267M
285
PRLD
Prelude Therapeutics Incorporated
$263M
286
ALT
Altimmune, Inc.
$252M
287
TENX
Tenax Therapeutics, Inc.
$247M
288
EPRX
Eupraxia Pharmaceuticals Inc.
$246M
289
ARCT
Arcturus Therapeutics Holdings Inc.
$244M
290
OBIO
Orchestra BioMed Holdings, Inc.
$244M
291
CDXS
Codexis, Inc.
$240M
292
CCCC
C4 Therapeutics, Inc.
$237M
293
IMAB
I-Mab
$237M
294
NVCT
Nuvectis Pharma, Inc.
$236M
295
PLYX
Polaryx Therapeutics, Inc. Common Stock
$234M
296
VYGR
Voyager Therapeutics, Inc.
$230M
297
IMRX
Immuneering Corporation
$220M
298
ELTX
Elicio Therapeutics, Inc.
$217M
299
ACHV
Achieve Life Sciences, Inc.
$214M
300
SLGL
Sol-Gel Technologies Ltd.
$211M
301
CNTX
Context Therapeutics Inc.
$210M
302
RNA
Atrium Therapeutics, Inc.
$210M
303
SRZN
Surrozen, Inc.
$210M
304
CRBU
Caribou Biosciences, Inc.
$208M
305
ELDN
Eledon Pharmaceuticals, Inc.
$207M
306
NKTX
Nkarta, Inc.
$207M
307
CHRS
Coherus Oncology, Inc.
$204M
308
MGNX
MacroGenics, Inc.
$204M
309
TARA
Protara Therapeutics, Inc.
$202M
310
REPL
Replimune Group, Inc.
$197M
311
FENC
Fennec Pharmaceuticals Inc.
$197M
312
IVVD
Invivyd, Inc.
$195M
313
IPSC
Century Therapeutics, Inc.
$194M
314
WHWK
Whitehawk Therapeutics Inc
$191M
315
HRTX
Heron Therapeutics, Inc.
$189M
316
SGMT
Sagimet Biosciences Inc.
$187M
317
QSI
Quantum-Si incorporated
$184M
318
MDWD
MediWound Ltd.
$182M
319
RNAC
Cartesian Therapeutics, Inc.
$181M
320
VXRT
Vaxart, Inc.
$174M
321
BDTX
Black Diamond Therapeutics, Inc.
$170M
322
MENS
Jyong Biotech Ltd. Ordinary Shares
$169M
323
TNXP
Tonix Pharmaceuticals Holding Corp.
$168M
324
MOLN
Molecular Partners AG
$167M
325
PRQR
ProQR Therapeutics N.V.
$166M
326
OABI
OmniAb, Inc.
$166M
327
MIST
Milestone Pharmaceuticals Inc.
$164M
328
SPRO
Spero Therapeutics, Inc.
$161M
329
ABOS
Acumen Pharmaceuticals, Inc.
$158M
330
UNCY
Unicycive Therapeutics, Inc.
$157M
331
AVTX
Avalo Therapeutics, Inc.
$157M
332
GALT
Galectin Therapeutics Inc.
$156M
333
FATE
Fate Therapeutics, Inc.
$155M
334
ORMP
Oramed Pharmaceuticals Inc.
$155M
335
ALPS
Alps Group Inc
$155M
336
AGEN
Agenus Inc.
$152M
337
HURA
TuHURA Biosciences, Inc.
$150M
338
CNTB
Connect Biopharma Holdings Limited
$142M
339
ADAG
Adagene Inc.
$138M
340
IKT
Inhibikase Therapeutics, Inc.
$135M
341
THAR
Tharimmune, Inc.
$133M
342
IPHA
Innate Pharma S.A.
$133M
343
CRBP
Corbus Pharmaceuticals Holdings, Inc.
$126M
344
KRRO
Korro Bio, Inc.
$123M
345
PYXS
Pyxis Oncology, Inc.
$122M
346
CNTN
Canton Strategic Holdings Inc
$119M
347
AARD
Aardvark Therapeutics, Inc. Common Stock
$117M
348
CRDF
Cardiff Oncology, Inc.
$117M
349
ANTX
AN2 Therapeutics, Inc.
$116M
350
SAVA
Cassava Sciences, Inc.
$115M
351
KLRS
Kalaris Therapeutics Inc
$114M
352
TNYA
Tenaya Therapeutics, Inc.
$114M
353
BMEA
Biomea Fusion, Inc.
$113M
354
HUMA
Humacyte, Inc.
$111M
355
SEER
Seer, Inc.
$111M
356
IFRX
InflaRx N.V.
$111M
357
PEPG
PepGen Inc.
$106M
358
TTRX
Turn Therapeutics Inc.
$104M
359
ANIX
Anixa Biosciences, Inc.
$103M
360
IMDX
Insight Molecular Diagnostics Inc.
$102M
361
ONCY
Oncolytics Biotech Inc.
$102M
362
VOR
Vor Biopharma Inc.
$97M
363
NTHI
Neonc Technologies Holdings, Inc.
$96M
364
GNLX
Genelux Corporation
$95M
365
CGTX
Cognition Therapeutics, Inc.
$95M
366
ALDX
Aldeyra Therapeutics, Inc.
$93M
367
CAMP
CAMP4 Therapeutics Corporation
$91M
368
DTIL
Precision BioSciences, Inc.
$91M
369
ALXO
ALX Oncology Holdings Inc.
$89M
370
EXOZ
eXoZymes, Inc.
$88M
371
IMUX
Immunic, Inc.
$87M
372
VTVT
vTv Therapeutics Inc.
$86M
373
GOSS
Gossamer Bio, Inc.
$86M
374
GANX
Gain Therapeutics, Inc.
$85M
375
IMMP
Immutep Limited
$84M
376
CSBR
Champions Oncology, Inc.
$83M
377
EQ
Equillium, Inc.
$79M
378
FLNA
Filana Therapeutics, Inc.
$79M
379
MCRB
Seres Therapeutics, Inc.
$78M
380
QTTB
Q32 Bio Inc.
$78M
381
ATYR
aTyr Pharma, Inc.
$78M
382
PMVP
PMV Pharmaceuticals, Inc.
$77M
383
XBIT
XBiotech Inc.
$77M
384
PLRX
Pliant Therapeutics, Inc.
$76M
385
TLSA
Tiziana Life Sciences Ltd
$76M
386
ICCC
ImmuCell Corporation
$76M
387
ACET
Adicet Bio, Inc.
$76M
388
SPRB
Spruce Biosciences, Inc.
$76M
389
NRXS
NeurAxis, Inc.
$75M
390
SGMO
Sangamo Therapeutics, Inc.
$75M
391
FBIO
Fortress Biotech, Inc.
$74M
392
KPTI
Karyopharm Therapeutics Inc.
$74M
393
VRCA
Verrica Pharmaceuticals Inc.
$73M
394
COYA
Coya Therapeutics, Inc.
$73M
395
BYSI
BeyondSpring Inc.
$70M
396
TCRX
TScan Therapeutics, Inc.
$70M
397
ACTU
Actuate Therapeutics Inc
$69M
398
ESLA
Estrella Immunopharma, Inc.
$68M
399
CBUS
Cibus, Inc.
$68M
400
MNOV
MediciNova, Inc.
$67M
401
OKUR
OnKure Therapeutics, Inc.
$66M
402
IMA
ImageneBio Inc
$65M
403
OKYO
OKYO Pharma Limited
$63M
404
ACRV
Acrivon Therapeutics, Inc. Common Stock
$61M
405
INO
Inovio Pharmaceuticals, Inc.
$61M
406
RANI
Rani Therapeutics Holdings, Inc.
$61M
407
CLNN
Clene Inc.
$59M
408
EDSA
Edesa Biotech, Inc.
$59M
409
HYFT
MindWalk Holdings Corp.
$58M
410
COEP
Coeptis Therapeutics, Inc.
$58M
411
CYPH
Cypherpunk Technologies Inc.
$57M
412
MGX
Metagenomi, Inc. Common Stock
$56M
413
TIL
Instil Bio, Inc.
$54M
414
INKT
MiNK Therapeutics, Inc.
$54M
415
KZR
Kezar Life Sciences, Inc.
$54M
416
ENTX
Entera Bio Ltd.
$52M
417
PDSB
PDS Biotechnology Corporation
$52M
418
NRXP
NRx Pharmaceuticals, Inc.
$51M
419
ATOS
Atossa Therapeutics, Inc.
$50M
420
NTRB
Nutriband Inc.
$49M
421
XLO
Xilio Therapeutics, Inc.
$48M
422
TELO
Telomir Pharmaceuticals, Inc. Common Stock
$48M
423
PYPD
PolyPid Ltd.
$47M
424
XFOR
X4 Pharmaceuticals, Inc.
$47M
425
MREO
Mereo BioPharma Group plc
$47M
426
NERV
Minerva Neurosciences, Inc.
$46M
427
CUE
Cue Biopharma, Inc.
$46M
428
ELUT
Elutia Inc.
$45M
429
GUTS
Fractyl Health, Inc. Common Stock
$45M
430
RLYB
Rallybio Corporation
$45M
431
SNSE
Sensei Biotherapeutics, Inc.
$43M
432
LITS
Lite Strategy, Inc.
$42M
433
ATRA
Atara Biotherapeutics, Inc.
$41M
434
HOWL
Werewolf Therapeutics, Inc.
$41M
435
GLTO
Galecto, Inc.
$40M
436
ALGS
Aligos Therapeutics, Inc.
$40M
437
ATHE
Alterity Therapeutics Limited
$39M
438
VERU
Veru Inc.
$37M
439
INMB
INmune Bio, Inc.
$37M
440
CRVO
CervoMed Inc.
$36M
441
ANEB
Anebulo Pharmaceuticals, Inc.
$35M
442
ANVS
Annovis Bio, Inc.
$35M
443
GRCE
Grace Therapeutics, Inc.
$35M
444
SABS
SAB Biotherapeutics, Inc.
$34M
445
BOLD
Boundless Bio, Inc.
$34M
446
LONA
LeonaBio, Inc.
$32M
447
LPTX
Leap Therapeutics, Inc.
$32M
448
RNXT
RenovoRx, Inc.
$31M
449
DYAI
Dyadic International, Inc.
$31M
450
TVGN
Tevogen Bio Holdings Inc.
$31M
451
SKYE
Skye Bioscience, Inc.
$31M
452
CING
Cingulate Inc.
$31M
453
TVRD
Tvardi Therapeutics, Inc.
$30M
454
BTAI
BioXcel Therapeutics, Inc.
$29M
455
LSTA
Lisata Therapeutics, Inc.
$29M
456
SNTI
Senti Biosciences, Inc.
$29M
457
EIKN
Eikon Therapeutics, Inc. Common Stock
$29M
458
NXTC
NextCure, Inc.
$28M
459
LTRN
Lantern Pharma Inc.
$28M
460
PLUR
Pluri Inc.
$27M
461
IBIO
iBio, Inc.
$27M
462
CELU
Celularity Inc.
$26M
463
EVAX
Evaxion Biotech A/S
$25M
464
BRNS
Barinthus Biotherapeutics plc
$25M
465
MPLT
MapLight Therapeutics, Inc.
$24M
466
LGVN
Longeveron Inc.
$22M
467
ENLV
Enlivex Therapeutics Ltd.
$22M
468
XCUR
Exicure, Inc.
$22M
469
ALLR
Allarity Therapeutics, Inc.
$21M
470
KLTO
Klotho Neurosciences, Inc.
$21M
471
DARE
Daré Bioscience, Inc.
$20M
472
KZIA
Kazia Therapeutics Limited
$20M
473
LEXX
Lexaria Bioscience Corp.
$20M
474
VTGN
VistaGen Therapeutics, Inc.
$19M
475
PASG
Passage Bio, Inc.
$19M
476
NRSN
NeuroSense Therapeutics Ltd.
$19M
477
OSRH
OSR Holdings, Inc.
$18M
478
TAOX
TAO Synergies Inc.
$17M
479
LIXT
Lixte Biotechnology Holdings, Inc.
$17M
480
PLRZ
Polyrizon Ltd.
$16M
481
PSTV
Plus Therapeutics, Inc.
$16M
482
ABVC
ABVC BioPharma, Inc.
$16M
483
MRKR
Marker Therapeutics, Inc.
$15M
484
COCP
Cocrystal Pharma, Inc.
$15M
485
APLM
Apollomics, Inc.
$15M
486
PMN
ProMIS Neurosciences, Inc.
$15M
487
SNGX
Soligenix, Inc.
$14M
488
CVKD
Cadrenal Therapeutics, Inc. Common Stock
$14M
489
JSPR
Jasper Therapeutics, Inc.
$14M
490
JUNS
Jupiter Neurosciences, Inc.
$14M
491
PHIO
Phio Pharmaceuticals Corp.
$14M
492
GNTA
Genenta Science S.p.A.
$14M
493
LPCN
Lipocine Inc.
$13M
494
OTLK
Outlook Therapeutics, Inc.
$13M
495
NCNA
NuCana plc
$13M
496
HIND
Vyome Holdings, Inc.
$13M
497
CYCN
Cyclerion Therapeutics, Inc.
$13M
498
CURX
Curanex Pharmaceuticals Inc Common Stock
$13M
499
ICU
SeaStar Medical Holding Corporation
$12M
500
BIVI
BioVie Inc.
$11M